covid 19 News and Research

RSS

Is SARS-CoV-2 a seasonal virus?

In a recent study posted to the medRxiv* pre-print server, scientists at Pfizer Inc determined whether coronavirus disease 2019 (COVID-19) case rates in the United States (US) and European (EU) nations followed a seasonal pattern using a time series model.

20 Jun 2022

Implications of impaired type I interferon immunity and increasing COVID-19 severity

Researchers demonstrated that impaired type I interferon immunity is associated with increasing coronavirus disease 2019 severity.

20 Jun 2022

The feasibility of sperm cryopreservation for male COVID-19 patients

In an article recently published in Frontiers in Endocrinology, scientists deciphered the possibility of cryopreserving sperm of coronavirus disease 2019 (COVID-19) patients

20 Jun 2022

Evaluating post-acute sequelae of COVID-19 using cardiopulmonary exercise testing

Researchers demonstrated reduced exercise capacity due to persistent cardiopulmonary symptoms among COVID-19 survivors hospitalized for acute infection and those having long COVID.

20 Jun 2022

SARS-CoV-2 spike circulating in most long COVID 12 months post-diagnosis

In a recent study posted to the medRxiv* preprint server, researchers explored the association between circulating coronavirus disease 2019 (COVID-19) antigens and post-COVID-19 sequelae (long COVID).

20 Jun 2022

Overt and occult hypoxemia in patients hospitalized with COVID-19

In a recent study posted to the medRxiv* preprint server, researchers assessed whether non-invasive estimation of the ratio of arterial oxygen partial pressure (PaO2) to the fractional inspired oxygen (Fi O2), i.e., the P/F ratio could measure overt and occult hypoxemia in coronavirus disease 2019 (COVID-19) patients.

20 Jun 2022

Model predicts effectiveness of COVID-19 vaccines against circulating SARS-CoV-2 variants

In a recent study published in the journal Nature Medicine, researchers assessed the coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) against symptomatic infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and variants of interest (VOIs) by genetic mismatch/distance (GD) analysis.

20 Jun 2022

How effective are mRNA COVID-19 vaccine boosters against Omicron?

In a recent study posted to the medRxiv* preprint server, researchers University of Washington, University of Michigan, Duke University, and Veterans Affairs Portland Healthcare System assessed the effectiveness of the coronavirus disease 2019 (COVID-19) booster vaccines.

19 Jun 2022

Long-COVID risk reduced with Omicron versus Delta

In a recent study published in The Lancet, researchers at King's College London and ZOE Limited assessed the risk of long coronavirus disease (COVID) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron variants in the United Kingdom (UK).

19 Jun 2022

Combating monkeypox during COVID-19

Scientists describe the global prevalence and significance of the current monkeypox virus outbreak.

19 Jun 2022

CHEST launches an empathetic health care initiative in Bexar County

Aimed at improving patient care, the American College of Chest Physicians (CHEST) is launching the First 5 Minutes™, an empathetic health care initiative, on June 18 in Bexar County, Texas.

18 Jun 2022

Disease ecologist receives $3.5 million to take modeling to the next level with EpiMoRPH

Mathematical modeling-;which combines math, statistics, computing and data-;is a critical tool for public health professionals, who use it to study how diseases spread, predict the future course of outbreaks and evaluate strategies for controlling epidemics.

18 Jun 2022

Researchers analyze SARS-CoV-2 virus transmission by speech aerosols during short conversations

When a person sneezes or coughs, they can potentially transmit droplets carrying viruses like SARS-CoV-2 to others in their vicinity.

17 Jun 2022

Adolescents and young adults less likely to get addiction treatment during the COVID-19 pandemic

A study analyzing prescription claims for a drug used to treat opioid addictions found that adolescents and young adults were less likely than usual to get treatment during the COVID-19 pandemic, especially if they were covered by private, commercial health insurance.

17 Jun 2022

covid 19 News and Research

Is SARS-CoV-2 a seasonal virus?

Implications of impaired type I interferon immunity and increasing COVID-19 severity

The feasibility of sperm cryopreservation for male COVID-19 patients

Evaluating post-acute sequelae of COVID-19 using cardiopulmonary exercise testing

SARS-CoV-2 spike circulating in most long COVID 12 months post-diagnosis

Overt and occult hypoxemia in patients hospitalized with COVID-19

Model predicts effectiveness of COVID-19 vaccines against circulating SARS-CoV-2 variants

How effective are mRNA COVID-19 vaccine boosters against Omicron?

Long-COVID risk reduced with Omicron versus Delta

Combating monkeypox during COVID-19

CHEST launches an empathetic health care initiative in Bexar County

Disease ecologist receives $3.5 million to take modeling to the next level with EpiMoRPH

Researchers analyze SARS-CoV-2 virus transmission by speech aerosols during short conversations

Adolescents and young adults less likely to get addiction treatment during the COVID-19 pandemic

Urgent action needed to clear heart surgery backlogs, research suggests

Neuropsychiatric symptoms among patients with long COVID

Effectiveness of previous COVID-19 and vaccination against SARS-CoV-2 Omicron infection

Assessing neurological symptoms present in long COVID patients

SARS-CoV-2 variant-specific polymerase chain reaction assay for SARS-CoV-2 genomic surveillance

Researchers investigate COVID fog and chemokine C–C motif ligand 11

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News